All crispr articles
-
BusinessUK becomes first country in the world to authorise a Crispr-based gene therapy
Treatment aims to cure patients with β-thalassaemia and sickle-cell disease
-
ResearchGenetic-editing of chickens protects them from catching the flu
Approach heralds new way to make animals resistant to disease
-
Research’This is just the beginning’: RNA editing set to democratise viral engineering
Crispr-based system could ease development of novel RNA therapies
-
NewsEuropean intellectual property system ready for gene-edited crops
Updates to New Genomic Technology regulations irrelevant to IP say experts
-
ResearchCrispr editing reduces poplar lignin content
Gene-edited wood could reduce waste and save energy during pulping process
-
NewsEuropean Commission set to propose an overhaul of rules for gene-edited crops
Leaked document reveals light touch regulation planned for crops engineering using precision techniques
-
NewsThe launch of a new field: precision microbiome editing
Nobel laureate Jennifer Doudna is helping lead a new $70 million project combining metagenomics and CRISPR to solve health, climate problems
-
NewsGene-edited crops and animals get the green light in England
Legislation holds out hope for agri-biotech industry that has found itself stifled by EU rules
-
ResearchGlow-in-the-dark proteins offer cheap and fast diagnostic tests
Covid-19 can be detected with the sensitivity of PCR and the ease of lateral flow
-
OpinionHuman genome editing in perspective
Ethical, cultural and safety considerations are high priorities for researchers
-
OpinionA decade on Crispr is already poised to deliver on its promise
Gene editing could transform healthcare but no disease should be forgotten
-
NewsCrispr moves into the clinic
A mere decade after its discovery Crispr is already in clinical trials for everything from sickle cell disease to HIV and cancer
-
ResearchCrispr editing of certain genes could trigger cell death
Researchers identify more than 3000 spots in the human genome where gene editing could cause toxic side effects and genomic instability
-
BusinessPatent office cements priority for Crispr gene editing in cells
Nobel laureates’ failed challenge means companies may need extra patent licenses
-
NewsUK to ease restrictions on gene editing in crops and livestock
Redefinition of genetically-modified organisms could see Crispr-edited foods brought to market
-
NewsUK approves Europe’s first field trials of Crispr-edited wheat
Field trials will examine how low-asparagine plants fare in the field
-
NewsUC Berkeley to auction off digital mementos of Nobel prize discoveries
Sale of digital data related to cancer immunotherapy and Crispr will be used to finance research
-
NewsEU genome-editing legislation is ‘unfit for purpose’ says European commission
Current policies lag behind the latest technological developments
-
OpinionRewards based on priority drive unnecessary competition
The story of Crispr illustrates how a focus on patents and publications can cause good people to act in unsavoury ways
-
NewsGovernment to review gene-editing regulations for animals and crops in England
Consultation seeks public’s view on genetically-modified organisms produced using tools such as Crispr